期刊文献+

乳腺癌改良根治术后化疗后相关预后因素分析 被引量:4

Study on the prognostic factors of breast cancer after modified radical mastectomy and chemotherapy
下载PDF
导出
摘要 目的探讨影响乳腺癌改良根治术后化疗后相关预后因素并建立预后预测模型。方法选择乳腺癌改良根治术后化疗后资料完整患者96例,收集相关预后因素并进行随访。采用单因素和多因素Cox模型分析,计算预后指数(PI)。结果肿瘤大小、组织病理学类型及腋窝淋巴结转移个数为影响预后的独立因子;由此建立的预后预测模型,具有较高的信度和效度;利用ROC曲线工作原理,当PI≤5.23时,乳腺癌改良根治术后化疗后3年预后结局较好。结论肿瘤大小、组织病理学类型及腋窝淋巴结转移个数为乳腺癌改良根治术后化疗后重要的预后指标,可为临床医师对乳腺癌改良根治术后化疗后患者个体预后结局估计提供有力的工具。 Objective To explore the factors related to the prognosis of breast cancer after modified radical masteetomy and chemotherapy, to establish a prognostic model for evaluating the prognosis of their patients. Methods 96 cases with breast cancer after modified radical masteetomy and chemotherapy were selected in this study and the factors related to the prognosis were collected and followed. Cox regression analysis was used for univariate and multivariate analysis. Prognostic index(PI) was calculated based on the results of multivariate a- nalysis. Results Univariate and multivariate analysis of Cox regression model were the tumor size, histopatho- logical type and number of axillary metastasis lymph nodes. A prognostic model was established. Breast cancer after modified radical mastectomy and chemotherapy had a better three-year outcome with PI ~〈 5.23 by ROC curves. Conclusions Histopathological type and number of axillary metastasis lymph nodes seem to be inde- pendent and important prognostic factors. This prognostic model could be used to evaluate the prognosis of pa- tients with breast cancer after modified radical masteetomy and chemotherapy by clinicians.
出处 《中国肿瘤外科杂志》 CAS 2013年第1期40-42,共3页 Chinese Journal of Surgical Oncology
关键词 乳腺癌 预后 化疗 乳腺癌改良根治术 COX模型 breast cancer prognosis chemotherapy modified radical mastectomy Cox regres-sion analysis
  • 相关文献

参考文献4

二级参考文献15

  • 1王华.癌周静脉癌栓和肝转移对大肠癌术后生存率的影响[J].肿瘤研究与临床,2004,16(4):270-271. 被引量:2
  • 2李斌,吴令英,李淑敏,章文华,张蓉,马绍康.子宫内膜癌的预后影响因素分析[J].癌症,2004,23(9):1085-1088. 被引量:31
  • 3惠锐.乳腺癌腋窝淋巴结转移规律的回顾性分析[J].肿瘤防治杂志,2004,11(9):933-936. 被引量:13
  • 4Chua B, Ung O, Taylor R, et al. Is there a role for anxillary dissection for patients with operable breast cancer in this ere of eonservatism?[J]. ANZ J Surg, 2002, 72(11): 786-792.
  • 5Chua B, Ung O, Taylor R. Frequen- cy and predictors of axillary lymph node metastases in invasive breast [J]. ANZJS, 2001, 71(12): 723-728.
  • 6Wright FC, Walker J, Law CH, et al. Outcome after localized axillary node recurrence in breast cancer [J]. Ann Surg Oncol, 2003, 10(9): 1054-1058.
  • 7Fredriksson I, Liljegren G, Amesson LG, et al. Consequences of axillary re- currence after conservative breast surgery[J].Br J Surg,2002,89(7):902-908.
  • 8Powell SN, Taghian AG, Kachnic LA, et al. Risk of lymphema after re- gional nodal irradiation with breast con- servation therapy [J]. Int J Radiat Oncol Biol Phys, 2003, 55(5): 1209-1215.
  • 9Silberman AW, McVay, Cohen JS, et al. Comprarative morbidiy of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer[J]. Ann Surg, 2004, 240(1): 7-8.
  • 10OBERMAIR A,WANNER C,SPEISER P,et al.The influence of vascular space involvement on the prognosis of patients with stage Ⅰb cervical carcinoma[J].Cancer,1998,82(4):689-696.

共引文献14

同被引文献35

  • 1袁永熙,袁正平,施浩,卢慧娟.乳腺癌患者整体康复情况调查[J].中国肿瘤临床与康复,2005,12(5):473-476. 被引量:28
  • 2赵卫红,徐兵河,张频,李青,赵龙妹,孙燕.乳腺癌合并脉管瘤栓的临床病理特点及预后因素分析[J].中华肿瘤杂志,2007,29(2):137-140. 被引量:14
  • 3刘文新.乳腺癌手术治疗的临床疗效及生存率分析[J].中国医药导刊,2012,(z2):462-463.
  • 4ZHANG S J, HU Y, QIAN H L, et al. Expression and signifi- cance of ER,PR,vegf,ca15-3,ca125 and cea in judging the prognosis of breast cancer[ J ]. Asian Pac J Cancer Prey,2013, 14 (6) :3937-3940.
  • 5van der SANGEN M J, POORTMANS P M, SCHEEPERS S W, et al. Prognosis following local recurrence after breast conser- ving treatment in young women with early breast cancer [ J ]. Eur J Surg 0ncol,2013,39(8) :892-898.
  • 6AMANT F,von MINCKWITZ G, HANS N, et al. Prognosis of women with primary breast cancer diagnosed during pregnan- cy:Results from an international collaborative study [ J ]. J Clin Oncol,2013,31 (20) :2532-2539.
  • 7WANG G S,ZHU H,BI S J. Pathological features and prognosis of different molecular subtypes of breast cancer [ J ]. Mol Med Rep,2012,6(4) :779-782.
  • 8PETEKKAYA I, AYYILDIZ V, KIZILARSLANOGLU M C,et al. Prognosis of breast cancer in patients with peritoneal me- tastasis[ J ]. Breast,2012,21 (3) :420-421.
  • 9Kuru B. Prognostic significance of total number of nodes re-moved,negative nodes removed,and ratio of positive nodes to removed nodes in node positive breast carcinoma[J].{H}EUROPEAN JOURNAL OF SURGICAL ONCOLOGY,2006,(10):1082-1088.
  • 10王淑莲,余子豪,李晔雄,唐源,亓姝楠,曹建忠,王文卿,李涛,金晶,王维虎,宋永文,刘新帆.乳腺癌改良根治术后复发高危患者的放疗结果和预后因素分析[J].中华放射肿瘤学杂志,2009,18(6):466-469. 被引量:8

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部